Exemplos de uso de Nonadherence to treatment em Inglês e suas traduções para o Português
{-}
-
Colloquial
-
Official
-
Medicine
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
This behavior was considered as being connected with nonadherence to treatment.
Nonadherence to treatment was identified as the leading cause of decompensation of HF.
The sample consisted of 417 patients with type 2 diabetes mellitus who have nonadherence to treatment.
In the present study, the rate of nonadherence to treatment was higher among patients who had visited the emergency room.
Despite the demonstration of inh effectiveness in preventing tb in plwha nonadherence to treatment has been common.
The risk of nonadherence to treatment was 3.6 times higher among patients without conditions of transportation 95% CI: 1.3-9.8.
In recent years, much research has been conducted in order to understand the causes orfactors associated with nonadherence to treatment.
Therefore, nonadherence to treatment constitutes a major obstacle to the effective treatment of cystic fibrosis.
The present study was developed with the aim of identifying determinants of nonadherence to treatment of hypertensive people in a city in the interior of goiás.
Mothers or caregivers must be able to follow recommendations to reduce VT of HIV;it is also important that people understand the risks involved in nonadherence to treatment.
The professionals in that study attributed nonadherence to treatment by people with CVU to factors such as non-cooperation and lack of motivation to follow through with the therapy.
The most common causes for resistant bacilli selection are the resistance to one ormore anti-TB drugs since the beginning of the treatment primary resistance or nonadherence to treatment.
The relationship between the healthcare team andits clientele includes the main factors for nonadherence to treatment, especially the physician-patient relationship, and the organization and structure of the PCU.
Nevertheless, subjective self-report techniques are easy to use and seem to allow, albeit with less sensitivity,the identification of a group of patients presenting nonadherence to treatment.
Even when individuals are diagnosed with ADHD, nonadherence to treatment may range from 13.2% to 64.0%(McCarthy, 2014) because of factors associated with lack of knowledge about the disorder and treatment Charach& Fernandez, 2013.
Although a number of patients respond satisfactorily to antipsychotics and antidepressants, 20-40% of them present inadequate response, and the treatment with ineffective medication may take weeks of unremitted illness,potential adverse drug reactions and nonadherence to treatment.
However, it is important to highlight that the problem of nonadherence to treatment of chronic conditions is complex; access to information about systemic hypertension does not necessarily imply higher adherence to therapeutic measures.
Therefore, we emphasize the importance of appropriate follow-up care for this population, with an emphasis on factors that lead to an unfavorable disease outcome,such as nonadherence to treatment, contact with asthma attack-triggering factors, improper use of inhalers, and lack of access to medications and medical care.
Faced with the above,the aim of this study was to validate the content of the dimensions constituting nonadherence to hypertensive treatment.
An electronic search with the terms"hypertension" and"cooperation of the patient" resulted in 123 specialists in adherence/nonadherence to hypertensive treatment.
The person dimension obtained an excellent IVC 1.0;p>0.001 and this result can be analyzed from the viewpoint of patient responsibility when facing nonadherence to hypertensive treatment.
For the content validation of the constituitive definitions,the literature review revealed a broad construct of the conceptualization of nonadherence to hypertensive treatment, with a systematic comprehension involving four dimensions.
Nonadherence to antihypertensive treatment can contribute to the hospitalization of the studied patients, considering that cardiovascular morbidity was significant both in hypertensive patients with and without chronic kidney disease.
For the definition of the sample, we conducted a search in the databases of the Coordination of Improvement of Higher Education Personnel CAPES in order to find potential specialists in adherence/nonadherence to the treatment of arterial hypertension to compose the sample.
For data collection, two forms were used: the first was to characterize the specialists, composed of socio-demographic and academic variables, and the second,for the validation of the content of the constitutive definitions of the dimensions of nonadherence to hypertension treatment.
Searching for an understanding goes beyond the biomedical view of nonadherence to hypertension treatment as a factor essentially linked to the person's behavior and use of medications.
A low educational level, a striking characteristic among those investigated in this study,may have repercussions in nonadherence to drug treatment and diet, which can trigger complications in CKD, such as osteodystrophy, a disease which affects the bones and causes intense pains.
Incorrect inhaler use can lead to treatment failure by reducing drug concentration in the airways and contribute to treatment nonadherence, making clinical asthma control difficult.
In this study, the dimensions of person with its psychological/cognitive, behavioral, family and economic subdimensions, illness/treatment andhealth service had its content validated by specialists in nonadherence to hypertensive treatment. The environment dimension and the biological subdimension were critical for engendering new research.
A new proposal for the understanding of the construct"nonadherence to hypertension treatment" was validated by a group of specialists, in an attempt to contribute to the deepening of this compelling theme that challenges the health system.